Global Vascular Graft Devices Market was valued at USD 2.73 billion in 2021, growing at a CAGR of 6.38% during the forecast period from 2022 to 2027 to reach USD 3.96 billion by 2027. Factors such as the rising prevalence of lifestyle disorders such as hypertension and diabetes which present themselves as major risk factors for the development of cardiovascular diseases such as aortic aneurysms and peripheral artery disease, growing geriatric population base where age itself plays a major role in disease etiology, and technical innovation in product development such as manufacture of coated vascular graft devices with improved features among other factors are expected to drive the vascular graft devices market.
Some of the key market players operating in the vascular graft devices market includes BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, and others.
Vascular Graft Device Overview
Vascular grafting (also known as vascular bypass) is a surgical procedure that reconnects blood vessels to direct blood flow from one area of the body to another. It is done by using vascular grafts that serve as channels for creating alternate passage for establishing blood supply.
Discover more about the Vascular Graft Device Report @ Vascular Graft Device Market Size
Recent Developmental Activities in Vascular Graft Devices Market:
- In October 2021, Terumo Aortic obtained the regulatory approval and the commercial launch of the Treo abdominal aortic stent graft system in Japan. The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) the Treo device as the treatment for abdominal aortic aneurysms.
- In June 2020, LeMaitre Vascular, Inc acquired the business and assets of Artegraft, Inc. for USD 90.0 million, thereby gaining access to Artegraft’s portfolio of biologic vascular grafts.
- In March 2020, SCITECH received the regulatory approval for their product SOLARIS which is a vascular endograft aimed at treating peripheral vascular disease. The device received the CE mark.
According to DelveInsight, the Vascular Graft Device Clinical Development Market would rise rapidly throughout the forecast period due to continuous commercial and clinical development.
Key Players working in the Vascular Graft Device Market Report
In the Global Vascular Graft Device Market Companies contribute significantly to their development and are also in mergers and acquisitions to strengthen their market position. Some of the key market players operating in the vascular graft devices market includes BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, and others.
Learn more about the Vascular Graft Device, get in-depth information of the report offering- Vascular Graft Device Market Outlook
Scope of the Vascular Graft Device Market Report
- Coverage- Global
- Study Period- 2019-2027
- Vascular Graft Devices Market Companies- BD, Getinge AB (NYSE: GETIB), Medtronic (NYSE: MDT), B. Braun Melsungen AG, Cardinal Health (NYSE: CAH), Terumo Corporation (NYSE: TRUMF), W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular Inc. (NYSE: LMAT), Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott (NYSE: ABT), Bentley, BioIntegral Surgical, Cook, Merit Medical Systems (NYSE: MMSI), SCITECH., Vascular Graft Solutions, and others.
- Vascular Graft Devices Market by Product Type (Endovascular Grafts [Abdominal and Thoracic], Access Grafts, Peripheral Grafts, and Others)
- Vascular Graft Devices Market By Type (Knitted, Woven, and Others)
- Vascular Graft Devices Market By Material (Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and Others)
- Vascular Graft Devices Market By End User (Hospitals, Ambulatory Surgical Centers, and Others)
- Vascular Graft Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
- Porter’s Five Forces Analysis, Product Profiles, Cases Studies, KOL’s Views, and Analyst’s View
Table of Content
- Vascular Graft Devices Market Report Introduction
- Vascular Graft Devices Market Executive Summary
- Regulatory Analysis
- Vascular Graft Devices Market Key Factor Analysis
- Vascular Graft Devices Market Porter’s Five Forces Analysis
- COVID-19 Impact Analysis on Vascular Graft Devices Market
- Vascular Graft Devices Market Layout
- Vascular Graft Devices Market Global Company Share Analysis – Key 3-5 Companies
- Vascular Graft Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
Reach out for more information of the Vascular Graft Devices Market Report @ Vascular Graft Devices Market Share
Key Takeaways from the Vascular Graft Devices Market Report Study
- Market analysis for current vascular graft devices market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular graft devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the global vascular graft devices market.
- Various opportunities available for the other competitor in the vascular graft devices market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current vascular graft devices market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for vascular graft devices market growth in the coming future?
Latest Pharmaceuticals Market Research Reports by DelveInsight
Aplastic Anemia Market | Chronic Traumatic Encephalopathy Market | Glaucoma Drainage Devices Market | ANCA Vasculitis Market | Neurogenic Detrusor Overactivity Market | Wiskott-aldrich Syndrome Market | Radiotherapy Induced Oral Mucositis Market | Advanced Liver Cancer Market | Complement 3 Glomerulopathy Market | Meibomian Gland Dysfunction Market | Metastatic Prostate Cancer Market | Thymidine Kinase 2 Deficiency Market | Spinocerebellar Ataxias Market | Urothelial Carcinoma Market | Hay Fever Conjunctivitis Market | Uncomplicated Urinary Tract Infection Market | AIDS Related Kaposi’s Sarcoma Market | Thrombotic Microangiopathy Market | Abdominal Aortic Aneurysm Market | Acute Myeloid Leukemia Market | Fabry Disease Market | Neuromyelitis Optica Market | Nocturia Market | Spinocerebellar Ataxia Market | Cardiac Monitoring Devices Market | Primary Ciliary Dyskinesia Market | Membranous Nephropathy Market | Convulsive Seizures Market | Bacterial Pneumonia Market | Myopia Progression Market | Exocrine Pancreatic Insufficiency EPI Market | Pacemakers Market | Elastomeric Pump Market | Oral Electrolyte Solutions Market | Inflammatory Pain Market | Retinal Neovascularization Market | Lice Infestations Market | Dermatomyositis Market | Thyroid Cancer Market | Venous Thromboembolism Market
Recent Published Blogs by DelveInsight
- What Compelling Applications is Brain-computer Interfacing Bringing to the Healthcare Market?
- Adial’s Micro-formulation: Opening New Massive Alcohol Use Disorder Treatment Market Opportunities
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash
info@delveinsight.com